1 intra-articular injectiondelivers up to1 full year ofromps and runs
NEW Synovetin OA™ breaks the cycle of inflammation and pain, clinically improving mobility and providing long-lasting relief.
Synovetin OA™ is a novel, conversion electron therapy that targets macrophages and synoviocytes in the injected joint.1,2
Provides durable pain and inflammation relief
Restores the active lifestyle of dogs with their families
Alters the course of chronic OA treatment
See how the dual cellular targeting of Synovetin OA™ works to deliver targeted treatment.
Delivers sustained, long-term relief2
Helps you more confidently manage patients
Answers a significant unmet need
Helps improve your canine patient's quality of life3
Provides targeted, non-systemic therapy1
Breaks the inflammatory cycle and improves mobility2
References
- Fox SM, Donecker JM. Synovitis Technical Bulletin. Exubrion Therapeutics July 2019.
- Data on File, Exubrion Therapeutics.
- American College of Veterinary Surgeons. Canine elbow dysplasia. Available at: https://www.acvs.org/small-animal/canine-elbow-dysplasia. Accessed 5/15/19.